Peter U Fischer

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

PLoS neglected tropical diseases

PloS one

Parasitology research

Pathogens (Basel, Switzerland)

Washington University in Saint Louis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington University in Saint Louis Feb 01 2005

United States

Professor of Medicine :: Infectious Diseases Division, Medicine

Publications

Liana Beld, Hyeim Jung, Christina A Bulman, Bruce A Rosa, Peter U Fischer, James W Janetka, Sara Lustigman, Judy A Sakanari, Makedonka Mitreva
Aspartyl Protease Inhibitors as Anti-Filarial Drugs. Pathogens (Basel, Switzerland) 11 (6) (2022)
Jonah Kupritz, John Martin, Kerstin Fischer, Kurt C Curtis, Joseph R Fauver, Yuefang Huang, Young-Jun Choi, Wandy L Beatty, Makedonka Mitreva, Peter U Fischer
Isolation and characterization of a novel bacteriophage WO from Allonemobius socius crickets in Missouri. PloS one 16 (7) (2021)
Kurt C Curtis, Kerstin Fischer, Young-Jun Choi, Makedonka Mitreva, Gary J Weil, Peter U Fischer
Characterization and localization of antigens for serodiagnosis of human paragonimiasis. Parasitology research 120 (2) (2021)
Obiora A Eneanya, Benjamin G Koudou, Meite Aboulaye, Aba Ange Elvis, Yeo Souleymane, Marie-Madeleine Kouakou, Gary J Weil, Peter U Fischer
Progress towards onchocerciasis elimination in Côte d'Ivoire: A geospatial modelling study. PLoS neglected tropical diseases 15 (2) (2021)
Alison Krentel, Nandha Basker, Madsen Beau de Rochars, Joshua Bogus, Daniel Dilliott, Abdel N Direny, Christine Dubray, Peter U Fischer, Adriani Lomi Ga, Charles W Goss, Myra Hardy, Cade Howard, Purushothaman Jambulingam, Christopher L King, Moses Laman, Jean Frantz Lemoine, Shruti Mallya, Leanne J Robinson, Josaia Samuela, Ken B Schechtman, Andrew C Steer, Taniawati Supali, Livingstone Tavul, Gary J Weil
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis. PLoS neglected tropical diseases 15 (3) (2021)
Taniawati Supali, Yenny Djuardi, Michael Christian, Elisa Iskandar, Rahmat Alfian, Roospita Maylasari, Yossi Destani, Adriani Lomiga, Dominikus Minggu, Daphne Lew, Joshua Bogus, Gary J Weil, Peter U Fischer
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia. PLoS neglected tropical diseases 15 (3) (2021)
Agodio Loukouri, Aboulaye Méité, Benjamin G Koudou, Charles W Goss, Daphne Lew, Gary J Weil, Eliezer K N'Goran, Peter U Fischer
Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire. PLoS neglected tropical diseases 14 (9) (2020)
Gary J Weil, Joshua Bogus, Michael Christian, Christine Dubray, Yenny Djuardi, Peter U Fischer, Charles W Goss, Myra Hardy, Purushothaman Jambulingam, Christopher L King, Vijesh Sridhar Kuttiat, Kaliannagounder Krishnamoorthy, Moses Laman, Jean Frantz Lemoine, Katiuscia K O'Brian, Leanne J Robinson, Josaia Samuela, Kenneth B Schechtman, Anita Sircar, Adinarayanan Srividya, Andrew C Steer, Taniawati Supali, Swaminathan Subramanian, null null
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study. PLoS medicine 16 (6) (2019)

Peter U Fischer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peter U Fischer